8-K/A

TAPIMMUNE 8KA 040309

Company: Marker Therapeutics, Inc.
Filed: April 10, 2009
Period of Report: February 4, 2009
Accession Number: 0001424884-09-000029

View Document ↗ View on SEC.gov ↗